Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum-based chemotherapy

被引：1

作者：

Nakatsuru, Kousei ^{[1
,2
]}

Tsubouchi, Kazuya ^{[1
,2
]}

Hirahata, Minori ^{[3
]}

Nakashima, Tadayuki ^{[1
]}

Takahata, Yuriko ^{[1
]}

Okamatsu, Yuki ^{[1
]}

Shiraishi, Yoshimasa ^{[2
]}

Okamoto, Isamu ^{[2
]}

Harada, Taishi ^{[1
]}

机构：

[1] Japan Community Hlth Care Org Kyushu Hosp, Dept Resp Med, Fukuoka, Japan

[2] Kyushu Univ, Grad Sch Med Sci, Dept Resp Med, Fukuoka, Japan

[3] Japan Community Hlth Care Org Kyushu Hosp, Dept Hematol, Fukuoka, Japan

来源：

THORACIC CANCER | 2023年 / 14卷 / 22期

关键词：

acute myeloid leukemia; autoimmune hemolytic anemia; immune checkpoint inhibitors; lung cancer; myelodysplastic syndrome; NEOPLASMS;

D O I：

10.1111/1759-7714.15005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Therapy related-acute myeloid leukemia (t-AML) and myelodysplastic syndrome (t-MDS) are complications of chemotherapy and/or radiation therapy for malignant diseases. In this report, we describe a patient with advanced lung adenocarcinoma who developed autoimmune hemolytic anemia and MDS associated with a combination of atezolizumab and platinum-based chemotherapy. The patient showed progression from t-MDS to t-AML 20 months after the treatment was initiated. A combination of immune checkpoint inhibitor (ICI) and chemotherapy may increase the risk of developing therapy-related myeloid neoplasms. As the prognosis of t-AML and t-MDS is poorer than that of de novo AML and MDS, proper surveillance, follow-up, and treatment are needed throughout the course of immunotherapy.

引用

收藏

页码：2225 / 2228

页数：4

相关论文

共 50 条

[41] Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies [J].

Uwe Platzbecker ;

Joerg Chromik ;

Jan Krönke ;

Hiroshi Handa ;

Stephen Strickland ;

Yasushi Miyazaki ;

Martin Wermke ;

Wataru Sakamoto ;

Yoshifumi Tachibana ;

Tillmann Taube ;

Ulrich Germing .

BMC Cancer, 22

[42] Sicca syndrome associated with immune checkpoint inhibitor therapy [J].

Harris, Jack A. ;

Huang, Kevin ;

Miloslavsky, Eli ;

Hanna, Glenn J. .

ORAL DISEASES, 2022, 28 (08) :2083-2092

[43] Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer [J].

Calip, Gregory S. ;

Malmgren, Judith A. ;

Lee, Wan-Ju ;

Schwartz, Stephen M. ;

Kaplan, Henry G. .

BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (01) :133-143

[44] A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia [J].

Liao, Dan ;

Wang, Mengyao ;

Liao, Yi ;

Li, Jun ;

Niu, Ting .

FRONTIERS IN PHARMACOLOGY, 2019, 10

[45] Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer [J].

Gregory S. Calip ;

Judith A. Malmgren ;

Wan-Ju Lee ;

Stephen M. Schwartz ;

Henry G. Kaplan .

Breast Cancer Research and Treatment, 2015, 154 :133-143

[46] Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse [J].

Glasser, Chana L. ;

Lee, Alice ;

Eslin, Don ;

Marks, Lianna ;

Modak, Shakeel ;

Bender, Julia L. Glade .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (07) :560-564

[47] Translocation t(11;17) in de novo Myelodysplastic Syndrome Not Associated with Acute Myeloid or Acute Promyelocytic Leukemia [J].

Baljevic, Muhamed ;

Abdel-Wahab, Omar ;

Rampal, Raajit ;

Maslak, Peter G. ;

Klimek, Virginia M. ;

Rosenblat, Todd L. ;

Douer, Dan ;

Levine, Ross L. ;

Tallman, Martin S. .

ACTA HAEMATOLOGICA, 2013, 129 (01) :48-54

[48] MDR1 GENE-EXPRESSION IN MYELODYSPLASTIC SYNDROME AND IN ACUTE MYELOID-LEUKEMIA EVOLVING FROM MYELODYSPLASTIC SYNDROME [J].

ZOCHBAUER, S ;

GSUR, A ;

GOTZL, M ;

WALLNER, J ;

LECHNER, K ;

PIRKER, R .

ANTICANCER RESEARCH, 1994, 14 (3B) :1293-1295

[49] Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations [J].

Matsumoto, Yosuke ;

Kato, Daishi ;

Muramatsu, Ayako ;

Sugitani, Mio ;

Kobayashi, Tsutomu ;

Iwai, Toshiki ;

Mori, Minako ;

Motooka, Daisuke ;

Nakata, Jun ;

Ogawa, Seishi ;

Nannya, Yasuhito ;

Uchiyama, Hitoji .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (06) :792-800

[50] TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome [J].

Niparuck, Pimjai ;

Police, Pornnapa ;

Noikongdee, Phichchapha ;

Siriputtanapong, Kanchana ;

Limsuwanachot, Nittaya ;

Rerkamnuaychoke, Budsaba ;

Chuncharunee, Suporn ;

Siriboonpiputtana, Teerapong .

DIAGNOSTIC PATHOLOGY, 2021, 16 (01)

← 1 2 3 4 5 →